Amazon Offers GLP-1 Weight-Loss Drugs to Medicare Patients for $50 a Month
Updated
Updated · Forbes · Aug 10
Amazon Offers GLP-1 Weight-Loss Drugs to Medicare Patients for $50 a Month
3 articles · Updated · Forbes · Aug 10
Summary
$50 monthly is the new price Amazon Pharmacy says eligible Medicare patients will pay for GLP-1 weight-loss drugs under the federal Medicare GLP-1 Bridge Program.
The move sharply lowers the cost of drugs such as Wegovy and Zepbound, which initially ran about $1,200 to $1,500 a month when they entered the market.
Amazon said the pricing change will save customers about $300 million while expanding access to obesity treatment through the Medicare-backed program.
The offer targets a large potential patient pool: 72% of U.S. adults age 20 and older were overweight or obese in 2023, according to CDC data.